Results 121 to 130 of about 4,898 (191)

In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates. [PDF]

Antibiotics (Basel)
Bölükbaşı Y, Öngen B.
europepmc   +1 more source

Comparative <i>in vitro</i> efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. [PDF]

Antimicrob Agents Chemother
Emeraud C, Dutkiewicz M, Dortet L.
europepmc   +1 more source

An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury. [PDF]

Antimicrob Agents Chemother
Hao M, Li Y, Bi Y, Liu S, Ju M.
europepmc   +1 more source

Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections. [PDF]

Antibiotics (Basel)
Keck JM.
europepmc   +1 more source

Cefiderocol Susceptibility and Carbapenemase Profiles in Carbapenem-Resistant Enterobacterales. [PDF]

Infect Dis Clin Microbiol
Bayrak A, Akçalı A, Mutlu R, Çakıcı N.   +3 more
europepmc   +1 more source

High prevalence of bla_NDM gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger. [PDF]

BMC Microbiol
Massir IN, Abdourahamane Y, Ounoussa T, Oumou H, Abdoulaye O, Ousmane A, Harouna M, Souleymane B, Doutchi M, Saidou M, Laminou IM.   +10 more
europepmc   +1 more source

Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement. [PDF]

Infect Dis Ther
Bleibtreu A, Bennis Y, Dinh A, Dupont H, Friggeri A, Jeannot K, Kipnis E, Zahar JR, CoRIS Cohort.   +8 more
europepmc   +1 more source

Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. [PDF]

Invest Ophthalmol Vis Sci
Romanowski EG, Young EK, Mandell JB, Dhaliwal DK, Mammen A, Jhanji V, Zegans ME, Shanks RMQ.   +7 more
europepmc   +1 more source

A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]

Antimicrob Agents Chemother
Arun B, Sharma R, Vallé Q, Bui NM, Furtado N, Ramirez MS, Rao G.   +6 more
europepmc   +1 more source

Characterization of KPC-160, a novel Ω-loop-deleted KPC variant on a dual-copy plasmid that confers cefiderocol resistance. [PDF]

Antimicrob Agents Chemother
Liu Y, Hong H, Huang Q, Fan L, Liu P, Wei D, Liu Y.   +6 more
europepmc   +1 more source